Novo taps Anthropic's Claude AI for drug discovery

The partnership demonstrates how large language models are evolving from chatbots into sophisticated tools for biochemical research and drug development. By integrating Claude, Novo Nordisk aims to accelerate the complex process of identifying novel therapeutic targets through advanced pattern recognition.